Table of Contents 1 Oral Vaccines Market Overview 1.1 Product Overview and Scope of Oral Vaccines 1.2 Oral Vaccines Segment by Type 1.2.1 Global Oral Vaccines Sales Growth Rate Comparison by Type (2021-2026) 1.2.2 Rotavirus Vaccine 1.2.3 Cholera Vaccine 1.2.4 Oral Polio Vaccine 1.2.5 Others 1.3 Oral Vaccines Segment by Application 1.3.1 Oral Vaccines Sales Comparison by Application: 2020 VS 2026 1.3.2 Public 1.3.3 Private 1.4 Global Oral Vaccines Market Size Estimates and Forecasts 1.4.1 Global Oral Vaccines Revenue 2015-2026 1.4.2 Global Oral Vaccines Sales 2015-2026 1.4.3 Oral Vaccines Market Size by Region: 2020 Versus 2026 2 Global Oral Vaccines Market Competition by Manufacturers 2.1 Global Oral Vaccines Sales Market Share by Manufacturers (2015-2020) 2.2 Global Oral Vaccines Revenue Share by Manufacturers (2015-2020) 2.3 Global Oral Vaccines Average Price by Manufacturers (2015-2020) 2.4 Manufacturers Oral Vaccines Manufacturing Sites, Area Served, Product Type 2.5 Oral Vaccines Market Competitive Situation and Trends 2.5.1 Oral Vaccines Market Concentration Rate 2.5.2 Global Top 5 and Top 10 Players Market Share by Revenue 2.5.3 Market Share by Company Type (Tier 1, Tier 2 and Tier 3) 2.6 Manufacturers Mergers & Acquisitions, Expansion Plans 2.7 Primary Interviews with Key Oral Vaccines Players (Opinion Leaders) 3 Oral Vaccines Retrospective Market Scenario by Region 3.1 Global Oral Vaccines Retrospective Market Scenario in Sales by Region: 2015-2020 3.2 Global Oral Vaccines Retrospective Market Scenario in Revenue by Region: 2015-2020 3.3 North America Oral Vaccines Market Facts & Figures by Country 3.3.1 North America Oral Vaccines Sales by Country 3.3.2 North America Oral Vaccines Sales by Country 3.3.3 U.S. 3.3.4 Canada 3.4 Europe Oral Vaccines Market Facts & Figures by Country 3.4.1 Europe Oral Vaccines Sales by Country 3.4.2 Europe Oral Vaccines Sales by Country 3.4.3 Germany 3.4.4 France 3.4.5 U.K. 3.4.6 Italy 3.4.7 Russia 3.5 Asia Pacific Oral Vaccines Market Facts & Figures by Region 3.5.1 Asia Pacific Oral Vaccines Sales by Region 3.5.2 Asia Pacific Oral Vaccines Sales by Region 3.5.3 China 3.5.4 Japan 3.5.5 South Korea 3.5.6 India 3.5.7 Australia 3.5.8 Taiwan 3.5.9 Indonesia 3.5.10 Thailand 3.5.11 Malaysia 3.5.12 Philippines 3.5.13 Vietnam 3.6 Latin America Oral Vaccines Market Facts & Figures by Country 3.6.1 Latin America Oral Vaccines Sales by Country 3.6.2 Latin America Oral Vaccines Sales by Country 3.6.3 Mexico 3.6.3 Brazil 3.6.3 Argentina 3.7 Middle East and Africa Oral Vaccines Market Facts & Figures by Country 3.7.1 Middle East and Africa Oral Vaccines Sales by Country 3.7.2 Middle East and Africa Oral Vaccines Sales by Country 3.7.3 Turkey 3.7.4 Saudi Arabia 3.7.5 U.A.E 4 Global Oral Vaccines Historic Market Analysis by Type 4.1 Global Oral Vaccines Sales Market Share by Type (2015-2020) 4.2 Global Oral Vaccines Revenue Market Share by Type (2015-2020) 4.3 Global Oral Vaccines Price Market Share by Type (2015-2020) 4.4 Global Oral Vaccines Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End 5 Global Oral Vaccines Historic Market Analysis by Application 5.1 Global Oral Vaccines Sales Market Share by Application (2015-2020) 5.2 Global Oral Vaccines Revenue Market Share by Application (2015-2020) 5.3 Global Oral Vaccines Price by Application (2015-2020) 6 Company Profiles and Key Figures in Oral Vaccines Business 6.1 Merck 6.1.1 Corporation Information 6.1.2 Merck Description, Business Overview and Total Revenue 6.1.3 Merck Oral Vaccines Sales, Revenue and Gross Margin (2015-2020) 6.1.4 Merck Products Offered 6.1.5 Merck Recent Development 6.2 GSK 6.2.1 GSK Oral Vaccines Production Sites and Area Served 6.2.2 GSK Description, Business Overview and Total Revenue 6.2.3 GSK Oral Vaccines Sales, Revenue and Gross Margin (2015-2020) 6.2.4 GSK Products Offered 6.2.5 GSK Recent Development 6.3 Sanofi 6.3.1 Sanofi Oral Vaccines Production Sites and Area Served 6.3.2 Sanofi Description, Business Overview and Total Revenue 6.3.3 Sanofi Oral Vaccines Sales, Revenue and Gross Margin (2015-2020) 6.3.4 Sanofi Products Offered 6.3.5 Sanofi Recent Development 6.4 Lanzhou Institute 6.4.1 Lanzhou Institute Oral Vaccines Production Sites and Area Served 6.4.2 Lanzhou Institute Description, Business Overview and Total Revenue 6.4.3 Lanzhou Institute Oral Vaccines Sales, Revenue and Gross Margin (2015-2020) 6.4.4 Lanzhou Institute Products Offered 6.4.5 Lanzhou Institute Recent Development 6.5 Serum Institute 6.5.1 Serum Institute Oral Vaccines Production Sites and Area Served 6.5.2 Serum Institute Description, Business Overview and Total Revenue 6.5.3 Serum Institute Oral Vaccines Sales, Revenue and Gross Margin (2015-2020) 6.5.4 Serum Institute Products Offered 6.5.5 Serum Institute Recent Development 6.6 Valneva 6.6.1 Valneva Oral Vaccines Production Sites and Area Served 6.6.2 Valneva Description, Business Overview and Total Revenue 6.6.3 Valneva Oral Vaccines Sales, Revenue and Gross Margin (2015-2020) 6.6.4 Valneva Products Offered 6.6.5 Valneva Recent Development 6.7 Shanghai United Cell 6.6.1 Shanghai United Cell Oral Vaccines Production Sites and Area Served 6.6.2 Shanghai United Cell Description, Business Overview and Total Revenue 6.6.3 Shanghai United Cell Oral Vaccines Sales, Revenue and Gross Margin (2015-2020) 6.4.4 Shanghai United Cell Products Offered 6.7.5 Shanghai United Cell Recent Development 6.8 Bibcol 6.8.1 Bibcol Oral Vaccines Production Sites and Area Served 6.8.2 Bibcol Description, Business Overview and Total Revenue 6.8.3 Bibcol Oral Vaccines Sales, Revenue and Gross Margin (2015-2020) 6.8.4 Bibcol Products Offered 6.8.5 Bibcol Recent Development 6.9 PaxVax 6.9.1 PaxVax Oral Vaccines Production Sites and Area Served 6.9.2 PaxVax Description, Business Overview and Total Revenue 6.9.3 PaxVax Oral Vaccines Sales, Revenue and Gross Margin (2015-2020) 6.9.4 PaxVax Products Offered 6.9.5 PaxVax Recent Development 6.10 Vabiotech 6.10.1 Vabiotech Oral Vaccines Production Sites and Area Served 6.10.2 Vabiotech Description, Business Overview and Total Revenue 6.10.3 Vabiotech Oral Vaccines Sales, Revenue and Gross Margin (2015-2020) 6.10.4 Vabiotech Products Offered 6.10.5 Vabiotech Recent Development 6.11 Tiantan Biological 6.11.1 Tiantan Biological Oral Vaccines Production Sites and Area Served 6.11.2 Tiantan Biological Oral Vaccines Description, Business Overview and Total Revenue 6.11.3 Tiantan Biological Oral Vaccines Sales, Revenue and Gross Margin (2015-2020) 6.11.4 Tiantan Biological Products Offered 6.11.5 Tiantan Biological Recent Development 6.12 EuBiologics 6.12.1 EuBiologics Oral Vaccines Production Sites and Area Served 6.12.2 EuBiologics Oral Vaccines Description, Business Overview and Total Revenue 6.12.3 EuBiologics Oral Vaccines Sales, Revenue and Gross Margin (2015-2020) 6.12.4 EuBiologics Products Offered 6.12.5 EuBiologics Recent Development 6.13 Panacea Biotec Ltd 6.13.1 Panacea Biotec Ltd Oral Vaccines Production Sites and Area Served 6.13.2 Panacea Biotec Ltd Oral Vaccines Description, Business Overview and Total Revenue 6.13.3 Panacea Biotec Ltd Oral Vaccines Sales, Revenue and Gross Margin (2015-2020) 6.13.4 Panacea Biotec Ltd Products Offered 6.13.5 Panacea Biotec Ltd Recent Development 6.14 Bio-Med 6.14.1 Bio-Med Oral Vaccines Production Sites and Area Served 6.14.2 Bio-Med Oral Vaccines Description, Business Overview and Total Revenue 6.14.3 Bio-Med Oral Vaccines Sales, Revenue and Gross Margin (2015-2020) 6.14.4 Bio-Med Products Offered 6.14.5 Bio-Med Recent Development 6.15 Halfkin Bio-Pharmaceuticals 6.15.1 Halfkin Bio-Pharmaceuticals Oral Vaccines Production Sites and Area Served 6.15.2 Halfkin Bio-Pharmaceuticals Oral Vaccines Description, Business Overview and Total Revenue 6.15.3 Halfkin Bio-Pharmaceuticals Oral Vaccines Sales, Revenue and Gross Margin (2015-2020) 6.15.4 Halfkin Bio-Pharmaceuticals Products Offered 6.15.5 Halfkin Bio-Pharmaceuticals Recent Development 7 Oral Vaccines Manufacturing Cost Analysis 7.1 Oral Vaccines Key Raw Materials Analysis 7.1.1 Key Raw Materials 7.1.2 Key Raw Materials Price Trend 7.1.3 Key Suppliers of Raw Materials 7.2 Proportion of Manufacturing Cost Structure 7.3 Manufacturing Process Analysis of Oral Vaccines 7.4 Oral Vaccines Industrial Chain Analysis 8 Marketing Channel, Distributors and Customers 8.1 Marketing Channel 8.2 Oral Vaccines Distributors List 8.3 Oral Vaccines Customers 9 Market Dynamics 9.1 Market Trends 9.2 Opportunities and Drivers 9.3 Challenges 9.4 Porter's Five Forces Analysis 10 Global Market Forecast 10.1 Global Oral Vaccines Market Estimates and Projections by Type 10.1.1 Global Forecasted Sales of Oral Vaccines by Type (2021-2026) 10.1.2 Global Forecasted Revenue of Oral Vaccines by Type (2021-2026) 10.2 Oral Vaccines Market Estimates and Projections by Application 10.2.1 Global Forecasted Sales of Oral Vaccines by Application (2021-2026) 10.2.2 Global Forecasted Revenue of Oral Vaccines by Application (2021-2026) 10.3 Oral Vaccines Market Estimates and Projections by Region 10.3.1 Global Forecasted Sales of Oral Vaccines by Region (2021-2026) 10.3.2 Global Forecasted Revenue of Oral Vaccines by Region (2021-2026) 10.4 North America Oral Vaccines Estimates and Projections (2021-2026) 10.5 Europe Oral Vaccines Estimates and Projections (2021-2026) 10.6 Asia Pacific Oral Vaccines Estimates and Projections (2021-2026) 10.7 Latin America Oral Vaccines Estimates and Projections (2021-2026) 10.8 Middle East and Africa Oral Vaccines Estimates and Projections (2021-2026) 11 Research Finding and Conclusion 12 Methodology and Data Source 12.1 Methodology/Research Approach 12.1.1 Research Programs/Design 12.1.2 Market Size Estimation 12.1.3 Market Breakdown and Data Triangulation 12.2 Data Source 12.2.1 Secondary Sources 12.2.2 Primary Sources 12.3 Author List 12.4 Disclaimer

List of Tables Table 1. Global Oral Vaccines Sales (M Doses) Growth Rate Comparison by Type (2015-2026) Table 2. Global Oral Vaccines Sales (M Doses) Comparison by Application: 2020 VS 2026 Table 3. Global Oral Vaccines Market Size by Type (M Doses) (US$ Million) (2020 VS 2026) Table 4. Global Key Oral Vaccines Manufacturers Covered in This Study Table 5. Global Oral Vaccines Sales (M Doses) by Manufacturers (2015-2020) Table 6. Global Oral Vaccines Sales Share by Manufacturers (2015-2020) Table 7. Global Oral Vaccines Revenue (Million USD) by Manufacturers (2015-2020) Table 8. Global Oral Vaccines Revenue Share by Manufacturers (2015-2020) Table 9. Global Market Oral Vaccines Average Price (USD/K Doses) of Key Manufacturers (2015-2020) Table 10. Manufacturers Oral Vaccines Sales Sites and Area Served Table 11. Manufacturers Oral Vaccines Product Types Table 12. Global Oral Vaccines Manufacturers Market Concentration Ratio (CR5 and HHI) Table 13. Global Oral Vaccines by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Oral Vaccines as of 2019) Table 14.Manufacturers Mergers & Acquisitions, Expansion Plans Table 15. Main Points Interviewed from Key Oral Vaccines Players Table 16. Global Oral Vaccines Sales (M Doses) by Region (2015-2020) Table 17. Global Oral Vaccines Sales Market Share by Region (2015-2020) Table 18. Global Oral Vaccines Revenue (Million US$) by Region (2015-2020) Table 19. Global Oral Vaccines Revenue Market Share by Region (2015-2020) Table 20. North America Oral Vaccines Sales by Country (2015-2020) (M Doses) Table 21. North America Oral Vaccines Sales Market Share by Country (2015-2020) Table 22. North America Oral Vaccines Revenue by Country (2015-2020) (US$ Million) Table 23. North America Oral Vaccines Revenue Market Share by Country (2015-2020) Table 24. Europe Oral Vaccines Sales by Country (2015-2020) (M Doses) Table 25. Europe Oral Vaccines Sales Market Share by Country (2015-2020) Table 26. Europe Oral Vaccines Revenue by Country (2015-2020) (US$ Million) Table 27. Europe Oral Vaccines Revenue Market Share by Country (2015-2020) Table 28. Asia Pacific Oral Vaccines Sales by Region (2015-2020) (M Doses) Table 29. Asia Pacific Oral Vaccines Sales Market Share by Region (2015-2020) Table 30. Asia Pacific Oral Vaccines Revenue by Region (2015-2020) (US$ Million) Table 31. Asia Pacific Oral Vaccines Revenue Market Share by Region (2015-2020) Table 32. Latin America Oral Vaccines Sales by Country (2015-2020) (M Doses) Table 33. Latin America Oral Vaccines Sales Market Share by Country (2015-2020) Table 34. Latin America Oral Vaccines Revenue by Country (2015-2020) (US$ Million) Table 35. Latin America Oral Vaccines Revenue Market Share by Country (2015-2020) Table 36. Middle East and Africa Oral Vaccines Sales by Country (2015-2020) (M Doses) Table 37. Middle East and Africa Oral Vaccines Sales Market Share by Country (2015-2020) Table 38. Middle East and Africa Oral Vaccines Revenue by Country (2015-2020) (US$ Million) Table 39. Middle East and Africa Oral Vaccines Revenue Market Share by Country (2015-2020) Table 40. Global Oral Vaccines Sales (M Doses) by Type (2015-2020) Table 41. Global Oral Vaccines Sales Share by Type (2015-2020) Table 42. Global Oral Vaccines Revenue (Million US$) by Type (2015-2020) Table 43. Global Oral Vaccines Revenue Share by Type (2015-2020) Table 44. Global Oral Vaccines Price (USD/K Doses) by Type (2015-2020) Table 45. Global Oral Vaccines Sales (M Doses) by Application (2015-2020) Table 46. Global Oral Vaccines Sales Market Share by Application (2015-2020) Table 47. Global Oral Vaccines Sales Growth Rate by Application (2015-2020) Table 48. Merck Oral Vaccines Corporation Information Table 49. Merck Description and Business Overview Table 50. Merck Oral Vaccines Sales (M Doses), Revenue (Million US$), Price (USD/K Doses) and Gross Margin (2015-2020) Table 51. Merck Main Product Table 52. Merck Recent Development Table 53. GSK Oral Vaccines Corporation Information Table 54. GSK Corporation Information Table 55. GSK Oral Vaccines Sales (M Doses), Revenue (Million US$), Price (USD/K Doses) and Gross Margin (2015-2020) Table 56. GSK Main Product Table 57. GSK Recent Development Table 58. Sanofi Oral Vaccines Corporation Information Table 59. Sanofi Corporation Information Table 60. Sanofi Oral Vaccines Sales (M Doses), Revenue (Million US$), Price (USD/K Doses) and Gross Margin (2015-2020) Table 61. Sanofi Main Product Table 62. Sanofi Recent Development Table 63. Lanzhou Institute Oral Vaccines Corporation Information Table 64. Lanzhou Institute Corporation Information Table 65. Lanzhou Institute Oral Vaccines Sales (M Doses), Revenue (Million US$), Price (USD/K Doses) and Gross Margin (2015-2020) Table 66. Lanzhou Institute Main Product Table 67. Lanzhou Institute Recent Development Table 68. Serum Institute Oral Vaccines Corporation Information Table 69. Serum Institute Corporation Information Table 70. Serum Institute Oral Vaccines Sales (M Doses), Revenue (Million US$), Price (USD/K Doses) and Gross Margin (2015-2020) Table 71. Serum Institute Main Product Table 72. Serum Institute Recent Development Table 73. Valneva Oral Vaccines Corporation Information Table 74. Valneva Corporation Information Table 75. Valneva Oral Vaccines Sales (M Doses), Revenue (Million US$), Price (USD/K Doses) and Gross Margin (2015-2020) Table 76. Valneva Main Product Table 77. Valneva Recent Development Table 78. Shanghai United Cell Oral Vaccines Corporation Information Table 79. Shanghai United Cell Corporation Information Table 80. Shanghai United Cell Oral Vaccines Sales (M Doses), Revenue (Million US$), Price (USD/K Doses) and Gross Margin (2015-2020) Table 81. Shanghai United Cell Main Product Table 82. Shanghai United Cell Recent Development Table 83. Bibcol Oral Vaccines Corporation Information Table 84. Bibcol Corporation Information Table 85. Bibcol Oral Vaccines Sales (M Doses), Revenue (Million US$), Price (USD/K Doses) and Gross Margin (2015-2020) Table 86. Bibcol Main Product Table 87. Bibcol Recent Development Table 88. PaxVax Oral Vaccines Corporation Information Table 89. PaxVax Corporation Information Table 90. PaxVax Oral Vaccines Sales (M Doses), Revenue (Million US$), Price (USD/K Doses) and Gross Margin (2015-2020) Table 91. PaxVax Main Product Table 92. PaxVax Recent Development Table 93. Vabiotech Oral Vaccines Corporation Information Table 94. Vabiotech Corporation Information Table 95. Vabiotech Oral Vaccines Sales (M Doses), Revenue (Million US$), Price (USD/K Doses) and Gross Margin (2015-2020) Table 96. Vabiotech Main Product Table 97. Vabiotech Recent Development Table 98. Tiantan Biological Oral Vaccines Corporation Information Table 99. Tiantan Biological Corporation Information Table 100. Tiantan Biological Oral Vaccines Sales (M Doses), Revenue (Million US$), Price (USD/K Doses) and Gross Margin (2015-2020) Table 101. Tiantan Biological Main Product Table 102. Tiantan Biological Recent Development Table 103. EuBiologics Oral Vaccines Corporation Information Table 104. EuBiologics Corporation Information Table 105. EuBiologics Oral Vaccines Sales (M Doses), Revenue (Million US$), Price (USD/K Doses) and Gross Margin (2015-2020) Table 106. EuBiologics Main Product Table 107. EuBiologics Recent Development Table 108. Panacea Biotec Ltd Oral Vaccines Corporation Information Table 109. Panacea Biotec Ltd Corporation Information Table 110. Panacea Biotec Ltd Oral Vaccines Sales (M Doses), Revenue (Million US$), Price (USD/K Doses) and Gross Margin (2015-2020) Table 111. Panacea Biotec Ltd Main Product Table 112. Panacea Biotec Ltd Recent Development Table 113. Bio-Med Oral Vaccines Corporation Information Table 114. Bio-Med Corporation Information Table 115. Bio-Med Oral Vaccines Sales (M Doses), Revenue (Million US$), Price (USD/K Doses) and Gross Margin (2015-2020) Table 116. Bio-Med Main Product Table 117. Bio-Med Recent Development Table 118. Halfkin Bio-Pharmaceuticals Oral Vaccines Corporation Information Table 119. Halfkin Bio-Pharmaceuticals Corporation Information Table 120. Halfkin Bio-Pharmaceuticals Oral Vaccines Sales (M Doses), Revenue (Million US$), Price (USD/K Doses) and Gross Margin (2015-2020) Table 121. Halfkin Bio-Pharmaceuticals Main Product Table 122. Halfkin Bio-Pharmaceuticals Recent Development Table 123. Sales Base and Market Concentration Rate of Raw Material Table 124. Key Suppliers of Raw Materials Table 125. Oral Vaccines Distributors List Table 126. Oral Vaccines Customers List Table 127. Market Key Trends Table 128. Key Opportunities and Drivers: Impact Analysis (2021-2026) Table 129. Key Challenges Table 130. Global Oral Vaccines Sales (M Doses) Forecast by Type (2021-2026) Table 131. Global Oral Vaccines Sales Market Share Forecast by Type (2021-2026) Table 132. Global Oral Vaccines Revenue (Million US$) Forecast by Type (2021-2026) Table 133. Global Oral Vaccines Revenue (Million US$) Market Share Forecast by Type (2021-2026) Table 134. Global Oral Vaccines Sales (M Doses) Forecast by Application (2021-2026) Table 135. Global Oral Vaccines Revenue (Million US$) Forecast by Application (2021-2026) Table 136. Global Oral Vaccines Sales (M Doses) Forecast by Region (2021-2026) Table 137. Global Oral Vaccines Sales Market Share Forecast by Region (2021-2026) Table 138. Global Oral Vaccines Revenue Forecast by Region (2021-2026) (US$ Million) Table 139. Global Oral Vaccines Revenue Market Share Forecast by Region (2021-2026) Table 140. Research Programs/Design for This Report Table 141. Key Data Information from Secondary Sources Table 142. Key Data Information from Primary Sources List of Figures Figure 1. Picture of Oral Vaccines Figure 2. Global Oral Vaccines Sales Market Share by Type: 2020 VS 2026 Figure 3. Rotavirus Vaccine Product Picture Figure 4. Cholera Vaccine Product Picture Figure 5. Oral Polio Vaccine Product Picture Figure 6. Others Product Picture Figure 7. Global Oral Vaccines Consumption Market Share by Application: 2020 VS 2026 Figure 8. Public Figure 9. Private Figure 10. Global Oral Vaccines Market Size 2015-2026 (US$ Million) Figure 11. Global Oral Vaccines Sales Capacity (M Doses) (2015-2026) Figure 12. Global Oral Vaccines Market Size Market Share by Region: 2020 Versus 2026 Figure 13. Oral Vaccines Sales Share by Manufacturers in 2020 Figure 14. Global Oral Vaccines Revenue Share by Manufacturers in 2019 Figure 15. The Global 5 and 10 Largest Players: Market Share by Oral Vaccines Revenue in 2019 Figure 16. Oral Vaccines Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019 Figure 17. Global Oral Vaccines Sales Market Share by Region (2015-2020) Figure 18. Global Oral Vaccines Sales Market Share by Region in 2019 Figure 19. Global Oral Vaccines Revenue Market Share by Region (2015-2020) Figure 20. Global Oral Vaccines Revenue Market Share by Region in 2019 Figure 21. North America Oral Vaccines Sales Market Share by Country in 2019 Figure 22. North America Oral Vaccines Revenue Market Share by Country in 2019 Figure 23. U.S. Oral Vaccines Sales Growth Rate (2015-2020) (M Doses) Figure 24. U.S. Oral Vaccines Revenue Growth Rate (2015-2020) (US$ Million) Figure 25. Canada Oral Vaccines Sales Growth Rate (2015-2020) (M Doses) Figure 26. Canada Oral Vaccines Revenue Growth Rate (2015-2020) (US$ Million) Figure 27. Europe Oral Vaccines Sales Market Share by Country in 2019 Figure 28. Europe Oral Vaccines Revenue Market Share by Country in 2019 Figure 29. Germany Oral Vaccines Sales Growth Rate (2015-2020) (M Doses) Figure 30. Germany Oral Vaccines Revenue Growth Rate (2015-2020) (US$ Million) Figure 31. France Oral Vaccines Sales Growth Rate (2015-2020) (M Doses) Figure 32. France Oral Vaccines Revenue Growth Rate (2015-2020) (US$ Million) Figure 33. U.K. Oral Vaccines Sales Growth Rate (2015-2020) (M Doses) Figure 34. U.K. Oral Vaccines Revenue Growth Rate (2015-2020) (US$ Million) Figure 35. Italy Oral Vaccines Sales Growth Rate (2015-2020) (M Doses) Figure 36. Italy Oral Vaccines Revenue Growth Rate (2015-2020) (US$ Million) Figure 37. Russia Oral Vaccines Sales Growth Rate (2015-2020) (M Doses) Figure 38. Russia Oral Vaccines Revenue Growth Rate (2015-2020) (US$ Million) Figure 39. Asia Pacific Oral Vaccines Sales Market Share by Region in 2019 Figure 40. Asia Pacific Oral Vaccines Revenue Market Share by Region in 2019 Figure 41. China Oral Vaccines Sales Growth Rate (2015-2020) (M Doses) Figure 42. China Oral Vaccines Revenue Growth Rate (2015-2020) (US$ Million) Figure 43. Japan Oral Vaccines Sales Growth Rate (2015-2020) (M Doses) Figure 44. Japan Oral Vaccines Revenue Growth Rate (2015-2020) (US$ Million) Figure 45. South Korea Oral Vaccines Sales Growth Rate (2015-2020) (M Doses) Figure 46. South Korea Oral Vaccines Revenue Growth Rate (2015-2020) (US$ Million) Figure 47. India Oral Vaccines Sales Growth Rate (2015-2020) (M Doses) Figure 48. India Oral Vaccines Revenue Growth Rate (2015-2020) (US$ Million) Figure 49. Australia Oral Vaccines Sales Growth Rate (2015-2020) (M Doses) Figure 50. Australia Oral Vaccines Revenue Growth Rate (2015-2020) (US$ Million) Figure 51. Taiwan Oral Vaccines Sales Growth Rate (2015-2020) (M Doses) Figure 52. Taiwan Oral Vaccines Revenue Growth Rate (2015-2020) (US$ Million) Figure 53. Indonesia Oral Vaccines Sales Growth Rate (2015-2020) (M Doses) Figure 54. Indonesia Oral Vaccines Revenue Growth Rate (2015-2020) (US$ Million) Figure 55. Thailand Oral Vaccines Sales Growth Rate (2015-2020) (M Doses) Figure 56. Thailand Oral Vaccines Revenue Growth Rate (2015-2020) (US$ Million) Figure 57. Malaysia Oral Vaccines Sales Growth Rate (2015-2020) (M Doses) Figure 58. Malaysia Oral Vaccines Revenue Growth Rate (2015-2020) (US$ Million) Figure 59. Philippines Oral Vaccines Sales Growth Rate (2015-2020) (M Doses) Figure 60. Philippines Oral Vaccines Revenue Growth Rate (2015-2020) (US$ Million) Figure 61. Vietnam Oral Vaccines Sales Growth Rate (2015-2020) (M Doses) Figure 62. Vietnam Oral Vaccines Revenue Growth Rate (2015-2020) (US$ Million) Figure 63. Latin America Oral Vaccines Sales Market Share by Country in 2019 Figure 64. Latin America Oral Vaccines Revenue Market Share by Country in 2019 Figure 65. Mexico Oral Vaccines Sales Growth Rate (2015-2020) (M Doses) Figure 66. Mexico Oral Vaccines Revenue Growth Rate (2015-2020) (US$ Million) Figure 67. Brazil Oral Vaccines Sales Growth Rate (2015-2020) (M Doses) Figure 68. Brazil Oral Vaccines Revenue Growth Rate (2015-2020) (US$ Million) Figure 69. Argentina Oral Vaccines Sales Growth Rate (2015-2020) (M Doses) Figure 70. Argentina Oral Vaccines Revenue Growth Rate (2015-2020) (US$ Million) Figure 71. Middle East and Africa Oral Vaccines Sales Market Share by Country in 2019 Figure 72. Middle East and Africa Oral Vaccines Revenue Market Share by Country in 2019 Figure 73. Turkey Oral Vaccines Sales Growth Rate (2015-2020) (M Doses) Figure 74. Turkey Oral Vaccines Revenue Growth Rate (2015-2020) (US$ Million) Figure 75. Saudi Arabia Oral Vaccines Sales Growth Rate (2015-2020) (M Doses) Figure 76. Saudi Arabia Oral Vaccines Revenue Growth Rate (2015-2020) (US$ Million) Figure 77. U.A.E Oral Vaccines Sales Growth Rate (2015-2020) (M Doses) Figure 78. U.A.E Oral Vaccines Revenue Growth Rate (2015-2020) (US$ Million) Figure 79. Sales Market Share of Oral Vaccines by Type (2015-2020) Figure 80. Sales Market Share of Oral Vaccines by Type in 2019 Figure 81. Revenue Share of Oral Vaccines by Type (2015-2020) Figure 82. Revenue Market Share of Oral Vaccines by Type in 2019 Figure 83. Global Oral Vaccines Sales Growth by Type (2015-2020) (M Doses) Figure 84. Global Oral Vaccines Sales Market Share by Application (2015-2020) Figure 85. Global Oral Vaccines Sales Market Share by Application in 2019 Figure 86. Global Revenue Share of Oral Vaccines by Application (2015-2020) Figure 87. Global Revenue Share of Oral Vaccines by Application in 2020 Figure 88. Merck Total Revenue (US$ Million): 2019 Compared with 2018 Figure 89. GSK Total Revenue (US$ Million): 2019 Compared with 2018 Figure 90. Sanofi Total Revenue (US$ Million): 2019 Compared with 2018 Figure 91. Lanzhou Institute Total Revenue (US$ Million): 2019 Compared with 2018 Figure 92. Serum Institute Total Revenue (US$ Million): 2019 Compared with 2018 Figure 93. Valneva Total Revenue (US$ Million): 2019 Compared with 2018 Figure 94. Shanghai United Cell Total Revenue (US$ Million): 2019 Compared with 2018 Figure 95. Bibcol Total Revenue (US$ Million): 2019 Compared with 2018 Figure 96. PaxVax Total Revenue (US$ Million): 2019 Compared with 2018 Figure 97. Vabiotech Total Revenue (US$ Million): 2019 Compared with 2018 Figure 98. Tiantan Biological Total Revenue (US$ Million): 2019 Compared with 2018 Figure 99. EuBiologics Total Revenue (US$ Million): 2019 Compared with 2018 Figure 100. Panacea Biotec Ltd Total Revenue (US$ Million): 2019 Compared with 2018 Figure 101. Bio-Med Total Revenue (US$ Million): 2019 Compared with 2018 Figure 102. Halfkin Bio-Pharmaceuticals Total Revenue (US$ Million): 2019 Compared with 2018 Figure 103. Price Trend of Key Raw Materials Figure 104. Manufacturing Cost Structure of Oral Vaccines Figure 105. Manufacturing Process Analysis of Oral Vaccines Figure 106. Oral Vaccines Industrial Chain Analysis Figure 107. Channels of Distribution Figure 108. Distributors Profiles Figure 109. Porter's Five Forces Analysis Figure 110. North America Oral Vaccines Sales (M Doses) and Growth Rate Forecast (2021-2026) Figure 111. North America Oral Vaccines Revenue (Million US$) and Growth Rate Forecast (2021-2026) Figure 112. Europe Oral Vaccines Sales (M Doses) and Growth Rate Forecast (2021-2026) Figure 113. Europe Oral Vaccines Revenue (Million US$) and Growth Rate Forecast (2021-2026) Figure 114. Latin America Oral Vaccines Sales (M Doses) and Growth Rate Forecast (2021-2026) Figure 115. Latin America Oral Vaccines Revenue (Million US$) and Growth Rate Forecast (2021-2026) Figure 116. Middle East and Africa Oral Vaccines Sales (M Doses) and Growth Rate Forecast (2021-2026) Figure 117. Middle East and Africa Oral Vaccines Revenue (Million US$) and Growth Rate Forecast (2021-2026) Figure 118. Asia Pacific Oral Vaccines Sales (M Doses) and Growth Rate Forecast (2021-2026) Figure 119. Asia Pacific Oral Vaccines Revenue (Million US$) and Growth Rate Forecast (2021-2026) Figure 120. Bottom-up and Top-down Approaches for This Report Figure 121. Data Triangulation Figure 122. Key Executives Interviewed

Merck GSK Sanofi Lanzhou Institute Serum Institute Valneva Shanghai United Cell Bibcol PaxVax Vabiotech Tiantan Biological EuBiologics Panacea Biotec Ltd Bio-Med Halfkin Bio-Pharmaceuticals